Pierre Kyme
Förmögenhet: 36 446 $ per 2026-05-31
Förmögenhet: 36 446 $ per 2026-05-31
Pierre Kyme currently works at Special Phage Services Pty Ltd., as Director, Special Phage Holdings Pty Ltd., as Director, AmpliPhi Australia Pty Ltd., as Director, C3J Therapeutics, Inc., as Director-Product Development from 2012, and Armata Pharmaceuticals, Inc., as Chief Business Officer from 2024.
Dr. Kyme received his doctorate degree from The University of Sydney.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-17 | 4 461 ( 0,01 % ) | 36 446 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Offentlig kommunikationskontakt | - |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Företagsledare/Principal | 2012-01-01 |
AmpliPhi Australia Pty Ltd.
AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Direktör/Styrelseledamot | - |
Special Phage Holdings Pty Ltd.
Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Direktör/Styrelseledamot | - |
Special Phage Services Pty Ltd.
Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Special Phage Services Pty Ltd.
Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Health Technology |
Special Phage Holdings Pty Ltd.
Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Health Technology |
AmpliPhi Australia Pty Ltd.
AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Health Technology |
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån